Category: Heart Failure
-
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
August 24, 2021Neprilysin Inhibitors to prevent LV remodeling post MI
-
-
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
August 21, 2021Impact of Dapagliflozin on the survival of HFrEF patients
-
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
-
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
July 12, 2021The fifth episode of Cardio-Watch: cardiometabolic disorders
-
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
July 5, 2021Diagnosis and management of Iron deficiency in HF patients
-
Cardio-Watch Podcast: Episode 4, Dyslipidemia
June 28, 2021The fourth episode of Cardio-Watch: Dyslipidemia
-
-
-
Left Atrial Appendage Occlusion to prevent Stroke
June 9, 2021Preventing Stroke by surgical LA Appendage Occlusion
-
Save the date; DiaBeat: The Beating Heart of Diabetes
June 8, 20216th Diabetes Masterclass for Cardiologists
-
Save the date: Cardiometabolic Grand Round 4th session
June 1, 2021The fourth session of Cardiometabolic grand round
-
Cardiopoint 12: Two-Drug Combinations as First-Step Antihypertensive treatment
May 30, 2021Initial administration of two-drug combinations in HTN
-
Cardio-Watch podcast: Episode 2, Hypertension
May 29, 2021The second episode of Cardio-Watch: Hypertension
-
Cardio-Watch Podcast: Episode one; COVID-19 and the heart
May 15, 2021The first episode of Cardio-Watch podcast
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (1st session)
April 10, 20211st Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Save the date; DiaBeat: The Beating Heart of Diabetes
February 23, 20214th Diabetes Masterclass for Cardiologists
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 7, 2021Quick review on place of Beta-Blockers in patients with HFrEF
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Guideline Directed Medical Therapy in Patients with HF
February 1, 2021Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)
-
Save the date; DiaBeat: The Beating Heart of Diabetes
January 28, 20213rd Diabetes Masterclass for Cardiologists
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
Impact: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomized, open-label trial
January 20, 2021Continue vs Stop of RAS inhibitors in patients with COVID-19
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: SGLT2 inhibition: Making waves in the heart failure landscape
December 31, 2020Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: Cardiometabolic Grand Round (2)
December 27, 2020A brief talk on DM medication challenges in patients with CVD
-
Impact: EMPA-RESPONSE-AHF
December 7, 2020Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)
-
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
December 7, 2020Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
December 3, 2020Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
-
A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)
December 2, 2020A quick review on the findings of TIPS-3 trial from AHA congress 2020
-
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
December 2, 2020The Important findings of SCORED trial from AHA 2020 congress in brief
-
High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)
December 2, 2020A quick review on the findings of INVESTED trial from AHA congress 2020
-
Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in HF (GALACTIC-HF Trial)
December 2, 2020A quick review on the findings of GALACTIC-HF trial from AHA congress 2020
-
Effects of Evolocumab on Complex Coronary Disease Requiring Revascularization
November 30, 2020Evolocumab in the pipeline
-
Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)
November 30, 2020Sotagliflozin in T2DM and exacerbated HF
-
Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)
November 26, 2020Iron supplementation in acute heart failure
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
November 3, 2020Part Two: Prevention of thromboembolic events Patients with AF and an ACS, PCI or CCS
-
Save the date: Cardiometabolic Grand Round
November 1, 2020A brief talk on DM management in patients with CVD
-
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Save the date: ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 31, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
At a glance; Place of FDC in CV outcomes
October 7, 2020Single-Pill Combination Therapy and CV Outcomes in HTN
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
October 3, 2020Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
-
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 2, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
The weight of the world: The global challenge of obesity
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (19)
September 16, 2020Part Nineteen: Trial Review, EXPLORER-HCM
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (13)
September 16, 2020Part Thirteen: Trial Review, BAMI
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (9)
September 16, 2020Part Nine: Trial Review, RATE-AF
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Impact: Mavacamten for the treatment of symptomatic HCM
August 31, 2020The findings of EXPLORER HCM trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
-
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
August 22, 2020A Brief Description on Practical Points in Anticoagulation
-
Case Discussion (29)
August 12, 2020Pharmacotherapy approach to ACE/ARB induced AKI in HFrEF patients
-
A music from the heart
August 8, 2020The S3 sound mixed into a delightful eastern melody by a talented Iranian physician
-
Case Discussion (24)
August 4, 2020Frequent VPB in a lady with HTN and mild LV systolic dysfunction
-
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD